The management of oral human papillomavirus with topical cidofovir: A case report

Scott S. DeRossi, Joel Laudenbach

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Cidofovir, a purine nucleotide analog of cytosine, has showed significant promise against a number of DNA viruses. In 1997, the US Food and Drug Administration approved the use of cidofovir intravenously in the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Recent studies and reports suggest that a topical form of cidofovir may be useful for treating viral cutaneous lesions recalcitrant to traditional treatments. We report the case of a 36-year-old man with human immunodeficiency virus (HIV) and recalcitrant human papillomavirus (HPV) lesions on the gingiva that were successfully treated with cidofovir gel 1%.

Original languageEnglish (US)
Pages (from-to)191-193
Number of pages3
JournalCutis
Volume73
Issue number3
StatePublished - Mar 1 2004

Fingerprint

Cytomegalovirus Retinitis
Purine Nucleotides
DNA Viruses
Cytosine
Gingiva
United States Food and Drug Administration
Acquired Immunodeficiency Syndrome
Gels
HIV
Skin
cidofovir
Therapeutics

ASJC Scopus subject areas

  • Dermatology

Cite this

DeRossi, S. S., & Laudenbach, J. (2004). The management of oral human papillomavirus with topical cidofovir: A case report. Cutis, 73(3), 191-193.

The management of oral human papillomavirus with topical cidofovir : A case report. / DeRossi, Scott S.; Laudenbach, Joel.

In: Cutis, Vol. 73, No. 3, 01.03.2004, p. 191-193.

Research output: Contribution to journalArticle

DeRossi, SS & Laudenbach, J 2004, 'The management of oral human papillomavirus with topical cidofovir: A case report', Cutis, vol. 73, no. 3, pp. 191-193.
DeRossi, Scott S. ; Laudenbach, Joel. / The management of oral human papillomavirus with topical cidofovir : A case report. In: Cutis. 2004 ; Vol. 73, No. 3. pp. 191-193.
@article{02e218c6c2054cd69253b34aead14a68,
title = "The management of oral human papillomavirus with topical cidofovir: A case report",
abstract = "Cidofovir, a purine nucleotide analog of cytosine, has showed significant promise against a number of DNA viruses. In 1997, the US Food and Drug Administration approved the use of cidofovir intravenously in the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Recent studies and reports suggest that a topical form of cidofovir may be useful for treating viral cutaneous lesions recalcitrant to traditional treatments. We report the case of a 36-year-old man with human immunodeficiency virus (HIV) and recalcitrant human papillomavirus (HPV) lesions on the gingiva that were successfully treated with cidofovir gel 1{\%}.",
author = "DeRossi, {Scott S.} and Joel Laudenbach",
year = "2004",
month = "3",
day = "1",
language = "English (US)",
volume = "73",
pages = "191--193",
journal = "Cutis",
issn = "0011-4162",
publisher = "Quadrant Healthcom Inc.",
number = "3",

}

TY - JOUR

T1 - The management of oral human papillomavirus with topical cidofovir

T2 - A case report

AU - DeRossi, Scott S.

AU - Laudenbach, Joel

PY - 2004/3/1

Y1 - 2004/3/1

N2 - Cidofovir, a purine nucleotide analog of cytosine, has showed significant promise against a number of DNA viruses. In 1997, the US Food and Drug Administration approved the use of cidofovir intravenously in the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Recent studies and reports suggest that a topical form of cidofovir may be useful for treating viral cutaneous lesions recalcitrant to traditional treatments. We report the case of a 36-year-old man with human immunodeficiency virus (HIV) and recalcitrant human papillomavirus (HPV) lesions on the gingiva that were successfully treated with cidofovir gel 1%.

AB - Cidofovir, a purine nucleotide analog of cytosine, has showed significant promise against a number of DNA viruses. In 1997, the US Food and Drug Administration approved the use of cidofovir intravenously in the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Recent studies and reports suggest that a topical form of cidofovir may be useful for treating viral cutaneous lesions recalcitrant to traditional treatments. We report the case of a 36-year-old man with human immunodeficiency virus (HIV) and recalcitrant human papillomavirus (HPV) lesions on the gingiva that were successfully treated with cidofovir gel 1%.

UR - http://www.scopus.com/inward/record.url?scp=1842506709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842506709&partnerID=8YFLogxK

M3 - Article

C2 - 15074348

AN - SCOPUS:1842506709

VL - 73

SP - 191

EP - 193

JO - Cutis

JF - Cutis

SN - 0011-4162

IS - 3

ER -